PMA P050047S086

Device
Juvéderm Ultra, Ultra XC, Juvéderm Ultra XC
Applicant
Allergan
PMA number
P050047
Supplement
S086
Product code
LMH
Decision date
2022-08-05
Generic name
Implant, dermal, for aesthetic use
Approval order statement
Implementing an additional duplicate syringe assembly and packaging line for manufacturing Juvéderm injectable gel products.

Current openFDA PMA Record#

Device
Juvéderm Ultra, Ultra XC, Juvéderm Ultra XC
Applicant
Allergan
PMA number
P050047
Supplement
S086
Product code
LMH
Generic name
Implant, dermal, for aesthetic use
Decision date
2022-08-05
Decision code
OK30
Date received
2022-07-07
Supplement type
30-Day Notice
Supplement reason
Process Change - Manufacturer/Sterilizer/Packager/Supplier
Approval order statement
Implementing an additional duplicate syringe assembly and packaging line for manufacturing Juvéderm injectable gel products.